Skip to content

GNTA

Genenta Science SpA

NASDAQ · Healthcare · Biotechnology · IT

$0.66
−2.40%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue72.7K27.0K46.5K41.7K6.0K
Gross Profit(72.7K)(27.0K)(46.5K)(41.7K)(6.0K)
Operating Expenses
R&D Expense7.5M2.6M5.0M6.4M5.2M
SG&A Expense8.8M3.7M5.1M5.1M5.6M
General & Admin Expense—————
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses16.3M6.3M10.2M11.5M10.8M
Cost and Expenses16.4M6.3M10.2M11.5M10.8M
Operating Income (EBIT)(16.4M)(6.3M)(10.2M)(11.5M)(10.8M)
Non-Operating
Interest Income968.4K968.7K———
Interest Expense373.5K384.2K———
Net Interest Income594.9K584.5K———
Other Non-Op Income/Expense972.2K71.0K889.8K85.9K2.5M
Non-Operating Income (excl Interest)(1.3M)(455.2K)(889.8K)(85.9K)(2.5M)
EBT (Pre-Tax Income)(15.4M)(6.3M)(9.3M)(11.4M)(8.3M)
Income Tax Expense—————
Bottom Line
Net Income(15.4M)(6.3M)(9.3M)(11.4M)(8.3M)
Earnings from Cont. Ops(15.4M)(6.3M)(9.3M)(11.4M)(8.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(15.4M)(6.3M)(9.3M)(11.4M)(8.3M)
Per Share
Basic EPS($0.82)($0.33)($0.49)($0.64)($0.47)
Diluted EPS($0.82)($0.33)($0.49)($0.64)($0.47)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding21.2M19.7M18.3M18.2M18.2M
Diluted Shares Outstanding21.2M19.7M18.3M18.2M18.2M
Profitability Metrics
EBITDA(15.0M)(5.9M)(9.3M)(11.4M)(8.3M)
D&A72.3K28.1K44.5K42.5K6.1K
EBIT(15.0M)(5.9M)(9.3M)(11.4M)(8.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025